• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建立了一个以奎尼酸诱导的 CRISPR/Cas9 基因组编辑系统,并将其应用于里氏木霉中伊利醇 H 生物合成的激活。

Development of a quinic acid-induced CRISPR/Cas9 genome editing system and its application for the activation of ilicicolin H biosynthesis in Trichoderma reesei.

机构信息

Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Shanxi Medical University, Taiyuan 030001, Shanxi, China; Shanxi Academy of Advanced Research and Innovation, Taiyuan 030032, Shanxi, China.

Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Shanxi Medical University, Taiyuan 030001, Shanxi, China.

出版信息

Int J Biol Macromol. 2024 Nov;279(Pt 4):135339. doi: 10.1016/j.ijbiomac.2024.135339. Epub 2024 Sep 6.

DOI:10.1016/j.ijbiomac.2024.135339
PMID:39245126
Abstract

The CRISPR/Cas9 genome editing tool has been extensively utilized in filamentous fungi, including Trichoderma reesei. However, most existing systems employ constitutive promoters for the expression of Cas9 protein within the cells or directly introduce Cas9 protein into the cells, which often leads to continuous expression of Cas9 resulting in undesired phenotypes or increased operational cost. In this study, we identified a quinic acid (QA)-induced qai5 promoter and employed it to express Cas9, thereby establishing an inducible genome editing system in T. reesei. By utilizing this system, we successfully edited the ypr1 gene and the silent gene cluster involved in ilicicolin H synthesis using donor DNA labeling 41-bp homology arm (HA), resulting in an editing efficiency ranging from 29.2 % to 46.7 %. Consequently, biosynthesis of ilicicolin H was achieved in T. reesei. To summarize, this study presents a novel form of CRISPR/Cas9 genome editing system that enables efficient and controllable genetic modifications in T. reesei.

摘要

CRISPR/Cas9 基因组编辑工具已被广泛应用于丝状真菌,包括里氏木霉。然而,大多数现有的系统在细胞内使用组成型启动子表达 Cas9 蛋白,或者直接将 Cas9 蛋白导入细胞,这通常导致 Cas9 的持续表达,从而导致不理想的表型或增加运营成本。在本研究中,我们鉴定了一种奎尼酸 (QA) 诱导的 qai5 启动子,并利用它来表达 Cas9,从而在里氏木霉中建立了一个诱导型基因组编辑系统。利用该系统,我们成功地编辑了 ypr1 基因和参与伊利西醇 H 合成的沉默基因簇,使用供体 DNA 标记 41-bp 同源臂 (HA),编辑效率范围为 29.2%至 46.7%。因此,在里氏木霉中实现了伊利西醇 H 的生物合成。总之,本研究提出了一种新型的 CRISPR/Cas9 基因组编辑系统,能够在里氏木霉中进行高效和可控的遗传修饰。

相似文献

1
Development of a quinic acid-induced CRISPR/Cas9 genome editing system and its application for the activation of ilicicolin H biosynthesis in Trichoderma reesei.建立了一个以奎尼酸诱导的 CRISPR/Cas9 基因组编辑系统,并将其应用于里氏木霉中伊利醇 H 生物合成的激活。
Int J Biol Macromol. 2024 Nov;279(Pt 4):135339. doi: 10.1016/j.ijbiomac.2024.135339. Epub 2024 Sep 6.
2
A simple approach to mediate genome editing in the filamentous fungus Trichoderma reesei by CRISPR/Cas9-coupled in vivo gRNA transcription.一种通过 CRISPR/Cas9 偶联体内 gRNA 转录在丝状真菌里氏木霉中进行基因组编辑的简单方法。
Biotechnol Lett. 2020 Jul;42(7):1203-1210. doi: 10.1007/s10529-020-02887-0. Epub 2020 Apr 16.
3
CRISPR/Cas9-mediated genome editing in Penicillium oxalicum and Trichoderma reesei using 5S rRNA promoter-driven guide RNAs.利用 5S rRNA 启动子驱动的向导 RNA,对草酸青霉和里氏木霉进行 CRISPR/Cas9 介导的基因组编辑。
Biotechnol Lett. 2021 Feb;43(2):495-502. doi: 10.1007/s10529-020-03024-7. Epub 2020 Oct 13.
4
CRISPR/Cas9-Mediated Genome Editing of Trichoderma reesei.CRISPR/Cas9 介导的里氏木霉基因组编辑。
Methods Mol Biol. 2021;2234:87-98. doi: 10.1007/978-1-0716-1048-0_8.
5
Efficient genome editing in filamentous fungi via an improved CRISPR-Cas9 ribonucleoprotein method facilitated by chemical reagents.通过化学试剂改进的 CRISPR-Cas9 核糖核蛋白方法实现丝状真菌中的高效基因组编辑。
Microb Biotechnol. 2021 Nov;14(6):2343-2355. doi: 10.1111/1751-7915.13652. Epub 2020 Aug 25.
6
Efficient genome editing in filamentous fungus Trichoderma reesei using the CRISPR/Cas9 system.利用CRISPR/Cas9系统在丝状真菌里氏木霉中进行高效基因组编辑。
Cell Discov. 2015 May 12;1:15007. doi: 10.1038/celldisc.2015.7. eCollection 2015.
7
Fast gene disruption in Trichoderma reesei using in vitro assembled Cas9/gRNA complex.利用体外组装的 Cas9/gRNA 复合物快速敲除里氏木霉中的基因。
BMC Biotechnol. 2019 Jan 9;19(1):2. doi: 10.1186/s12896-018-0498-y.
8
An efficient CRISPR/Cas9 genome editing system based on a multiple sgRNA processing platform in Trichoderma reesei for strain improvement and enzyme production.一种基于里氏木霉多sgRNA加工平台的高效CRISPR/Cas9基因组编辑系统,用于菌株改良和酶生产。
Biotechnol Biofuels Bioprod. 2024 Feb 11;17(1):22. doi: 10.1186/s13068-024-02468-7.
9
Employment of the CRISPR/Cas9 system to improve cellulase production in Trichoderma reesei.利用 CRISPR/Cas9 系统提高里氏木霉纤维素酶的产量。
Biotechnol Adv. 2022 Nov;60:108022. doi: 10.1016/j.biotechadv.2022.108022. Epub 2022 Jul 21.
10
Two CRISPR/Cas9 Systems Developed in Thermomyces dupontii and Characterization of Key Gene Functions in Thermolide Biosynthesis and Fungal Adaptation.Thermomyces dupontii 中开发的两个 CRISPR/Cas9 系统及其在 Thermolide 生物合成和真菌适应中的关键基因功能的表征。
Appl Environ Microbiol. 2020 Oct 1;86(20). doi: 10.1128/AEM.01486-20.

引用本文的文献

1
Regulation and induction of fungal secondary metabolites: a comprehensive review.真菌次生代谢产物的调控与诱导:综述
Arch Microbiol. 2025 Jul 1;207(8):189. doi: 10.1007/s00203-025-04386-0.
2
Advances in the discovery and study of natural products for biological control applications.用于生物防治应用的天然产物的发现与研究进展。
Nat Prod Rep. 2025 Jun 6. doi: 10.1039/d5np00017c.
3
Advances in CRISPR/Cas9-Based Gene Editing in Filamentous Fungi.基于CRISPR/Cas9的丝状真菌基因编辑研究进展
J Fungi (Basel). 2025 May 1;11(5):350. doi: 10.3390/jof11050350.
4
Discovery of the antifungal compound ilicicolin K through genetic activation of the ilicicolin biosynthetic pathway in Trichoderma reesei.通过里氏木霉中伊利西考林生物合成途径的基因激活发现抗真菌化合物伊利西考林K。
Biotechnol Biofuels Bioprod. 2025 Mar 11;18(1):32. doi: 10.1186/s13068-025-02628-3.
5
Current Knowledge on CRISPR Strategies Against Antimicrobial-Resistant Bacteria.关于对抗耐药细菌的CRISPR策略的当前知识
Antibiotics (Basel). 2024 Nov 27;13(12):1141. doi: 10.3390/antibiotics13121141.